Eledon Pharmaceuticals's total assets for Q2 2024 were $120.48M, an increase of 49.08% from the previous quarter. ELDN total liabilities were $128.98M for the fiscal quarter, a 2050.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.